A favourable political and financial environment, a talent pool, a cutting-edge research infrastructure and a geographic location that opens onto North America and Europe: Montréal offers the best conditions for success for companies in the life sciences and health technologies (LSHT) sector.
Montréal’s LSHT ecosystem has developed into a concentration of strong niches of excellence in which scientific and industrial partnerships broaden. The quick emergence of health technologies, personalized medicine and genomics also acts as a vehicle for innovation for industries. The Montréal metropolitan area is a talent incubator that brings together a critical mass of entrepreneurs, researchers and investors, who give rise and generate the treatments and medicine technologies of tomorrow.
Expertises of Greater Montreal
The LSHT sector first brings together companies that are dedicated to health, both human and animal, and which are found in one of the seven (7) sub-sectors of innovative pharmaceuticals, medical technologies, bitotechnologies, health information technology and artificial intelligence (health IT / AI), contract research organizations (CRO), contract manufacturing organizations (CMOs) and natural health products.
A sector that contributes to the economy
In the LSHT industry, Montréal alone contributes to 79% of GDP, an amount totalling $4.5 billion, out of $5.8 billion of Québec’s GDP.
The LSHT sector creates 75% more value added per direct job than all other sectors of economic activity in Quebec. Québec is ranked 6th in North America in relation to the share of total R&D expenses, all sectors combined, with respect to its GDP